CareX SA

company

About

CareX SA is a biopharmaceutical company focused on metabolic disease.

Details

Last Funding Type
Series B
Last Funding Money Raised
$32M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2001
Operating Status
Active

CareX SA is a biopharmaceutical company that develops novel treatments for metabolic and immune system disorders which includes diabetes and obesity. The company focuses on metabolic syndrome, a cluster of inter-related disorders of the body’s metabolism, including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol levels, that exposes individuals to the development of type 2 diabetes, heart diseases, and strokes.

CareX SA is a France-based company that was founded in 2001 and the company was acquired by 7TM Pharma on May 24, 2006.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$32M
CareX SA has raised a total of $32M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2004 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2004 Series B $32M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CareX SA is funded by 1 investors. Crédit Lyonnais Private Equity are the most recent investors.
Investor Name Lead Investor Funding Round
Crédit Lyonnais Private Equity Series B